Cellectar Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-12-31 was -7.50K shares.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 55.00 shares.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 166.00 shares, a 80.07% decline from fiscal 2015.
- Cellectar Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 833.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-12-31 | 55.00 shares 10-K · filed 2026-03-04 | |
| 2016-12-31 | 166.00 shares 10-K · filed 2017-03-15 | |
| 2015-12-31 | -7.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 833.00 shares 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |